The biopharmaceutical industry provides groundbreaking cures worldwide and is a significant economic driver in New Jersey.
In 2010, over 50,000 jobs in New Jersey were directly supported by the life sciences industry, and data from The Healthcare Institute of New Jersey (HINJ) shows a combined $53.5 billion total economic impact in New Jersey by HINJ member companies in 2009 and 2010.
Facilities like the one in Springfield train skilled craftsmen and women to build efficient, state-of-the-art manufacturing facilities that help foster innovation in the industry. To encourage medical innovation, trade unions invest over $800 million annually, at no taxpayer expense, to teach the latest techniques and skills to their workers.
As a result, pharmaceutical companies have a pool of highly skilled workers at their fingertips.
New Jersey is home to more pharmaceutical companies than any other state in the country, or any other country in the world. The pharmaceutical and medical technology industry is a major factor in creating a thriving economy in New Jersey, as well as making New Jersey a leader in research and development.
HINJ works closely with organized labor to raise awareness, understanding and public support for the research based pharmaceutical and medical technology industry.